Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Nov-22 4:15 PM View:  | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Nov-22 | Option Sale | 63 | $0.98 | $61.91 | (< 1%) 23.35K to 23.29K | |
| 03-Nov-22 4:15 PM View: | Ivers-Read Gillian C See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Nov-22 | Option Sale | 3,681 | $0.98 | $3,618.05 | (1%) 297.29K to 293.61K | |
| 03-Nov-22 4:15 PM View: | Rolfe Lindsey See remarks | Clovis Oncology, Inc. (CLVS) | 02-Nov-22 | Option Sale | 4,261 | $0.98 | $4,188.14 | (4%) 117.95K to 113.69K | |
| 03-Nov-22 4:15 PM View: | Gross Paul Edward See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Nov-22 | Option Sale | 4,730 | $0.98 | $4,649.12 | (5%) 103.06K to 98.33K | |
| 03-Nov-22 4:15 PM View: | Muehl Daniel W See remarks | Clovis Oncology, Inc. (CLVS) | 02-Nov-22 | Option Sale | 4,579 | $0.98 | $4,501.16 | (4%) 109.41K to 104.83K | |
| 03-Nov-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Nov-22 | Option Sale | 1,703 | $0.98 | $1,673.88 | (7%) 25.05K to 23.35K | |
| 03-Nov-22 4:15 PM View: | Rolfe Lindsey See remarks | Clovis Oncology, Inc. (CLVS) | 01-Nov-22 | Option Exercise | 8,374 | -- | -- | 8% 107.67K to 116.04K | |
| 03-Nov-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Nov-22 | Option Exercise | 3,374 | -- | -- | 16% 20.71K to 24.09K | |
| 03-Nov-22 4:15 PM View: | Muehl Daniel W See remarks | Clovis Oncology, Inc. (CLVS) | 01-Nov-22 | Option Exercise | 10,248 | -- | -- | 11% 96.65K to 106.9K | |
| 03-Nov-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Nov-22 | Option Exercise | 181 | -- | -- | < 1% 24.09K to 24.27K | |
| 03-Nov-22 4:15 PM View: | Ivers-Read Gillian C See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Nov-22 | Option Exercise | 8,374 | -- | -- | 3% 287.24K to 295.62K | |
| 03-Nov-22 4:15 PM View: | Gross Paul Edward See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Nov-22 | Option Exercise | 10,248 | -- | -- | 11% 90.22K to 100.47K | |
| 04-Oct-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 03-Oct-22 | Option Sale | 6 | $1.29 | $7.74 | (< 1%) 21.5K to 21.5K | |
| 04-Oct-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Oct-22 | Option Exercise | 15 | -- | -- | < 1% 21.49K to 21.5K | |
| 06-Sep-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Sep-22 | Option Sale | 172 | $1.20 | $206.40 | (< 1%) 21.66K to 21.49K | |
| 06-Sep-22 4:15 PM View: | Ivers-Read Gillian C See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Sep-22 | Option Sale | 2,234 | $1.20 | $2,680.80 | (< 1%) 291.15K to 288.92K | |
| 06-Sep-22 4:15 PM View: | Rolfe Lindsey See remarks | Clovis Oncology, Inc. (CLVS) | 02-Sep-22 | Option Sale | 2,545 | $1.20 | $3,054.00 | (2%) 112.12K to 109.58K | |
| 06-Sep-22 4:15 PM View: | Gross Paul Edward See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Sep-22 | Option Sale | 2,308 | $1.20 | $2,769.60 | (2%) 95.12K to 92.81K | |
| 06-Sep-22 4:15 PM View: | Muehl Daniel W See remarks | Clovis Oncology, Inc. (CLVS) | 02-Sep-22 | Option Sale | 2,234 | $1.20 | $2,680.80 | (2%) 101.39K to 99.16K | |
| 06-Sep-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Sep-22 | Option Sale | 1,444 | $1.20 | $1,732.80 | (6%) 23.11K to 21.66K | |
| 06-Sep-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Sep-22 | Option Exercise | 2,896 | -- | -- | 15% 19.7K to 22.6K | |
| 06-Sep-22 4:15 PM View: | Muehl Daniel W See remarks | Clovis Oncology, Inc. (CLVS) | 01-Sep-22 | Option Exercise | 5,063 | -- | -- | 5% 96.33K to 101.39K | |
| 06-Sep-22 4:15 PM View: | Ivers-Read Gillian C See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Sep-22 | Option Exercise | 5,063 | -- | -- | 2% 286.09K to 291.15K | |
| 06-Sep-22 4:15 PM View: | Gross Paul Edward See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Sep-22 | Option Exercise | 5,063 | -- | -- | 6% 90.06K to 95.12K | |
| 06-Sep-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Sep-22 | Option Exercise | 508 | -- | -- | 2% 22.6K to 23.11K | |
| 06-Sep-22 4:15 PM View: | Rolfe Lindsey See remarks | Clovis Oncology, Inc. (CLVS) | 01-Sep-22 | Option Exercise | 5,063 | -- | -- | 5% 107.06K to 112.12K | |
| 03-Aug-22 4:16 PM View: | Muehl Daniel W See remarks | Clovis Oncology, Inc. (CLVS) | 02-Aug-22 | Option Sale | 4,654 | $1.46 | $6,799.03 | (5%) 100.99K to 96.33K | |
| 03-Aug-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Aug-22 | Option Sale | 1,732 | $1.46 | $2,530.45 | (8%) 21.51K to 19.78K | |
| 03-Aug-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Aug-22 | Option Sale | 77 | $1.46 | $112.48 | (< 1%) 19.78K to 19.7K | |
| 03-Aug-22 4:15 PM View: | Ivers-Read Gillian C See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Aug-22 | Option Sale | 3,802 | $1.46 | $5,554.72 | (1%) 289.89K to 286.09K | |
| 03-Aug-22 4:15 PM View: | Rolfe Lindsey See remarks | Clovis Oncology, Inc. (CLVS) | 02-Aug-22 | Option Sale | 4,330 | $1.46 | $6,325.70 | (4%) 111.39K to 107.06K | |
| 03-Aug-22 4:15 PM View: | Gross Paul Edward See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Aug-22 | Option Sale | 4,807 | $1.46 | $7,023.51 | (5%) 94.86K to 90.06K | |
| 03-Aug-22 4:15 PM View: | Gross Paul Edward See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Aug-22 | Option Exercise | 10,249 | -- | -- | 13% 81.98K to 92.23K | |
| 03-Aug-22 4:15 PM View: | Rolfe Lindsey See remarks | Clovis Oncology, Inc. (CLVS) | 01-Aug-22 | Option Exercise | 8,374 | -- | -- | 8% 101.08K to 109.45K | |
| 03-Aug-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Aug-22 | Option Exercise | 3,376 | -- | -- | 20% 17.15K to 20.53K | |
| 03-Aug-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Aug-22 | Option Exercise | 181 | -- | -- | < 1% 20.53K to 20.71K | |
| 03-Aug-22 4:16 PM View: | Muehl Daniel W See remarks | Clovis Oncology, Inc. (CLVS) | 01-Aug-22 | Option Exercise | 10,249 | -- | -- | 12% 88.18K to 98.43K | |
| 03-Aug-22 4:15 PM View: | Ivers-Read Gillian C See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Aug-22 | Option Exercise | 8,374 | -- | -- | 3% 279.82K to 288.19K | |
| 06-Jul-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 05-Jul-22 | Option Sale | 7 | $2.71 | $18.97 | (< 1%) 17.96K to 17.95K | |
| 06-Jul-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Jul-22 | Option Exercise | 16 | -- | -- | < 1% 17.95K to 17.96K | |
| 03-Jun-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Jun-22 | Option Sale | 218 | $0.64 | $140.04 | (1%) 18.16K to 17.95K | |
| 03-Jun-22 4:15 PM View: | Ivers-Read Gillian C See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Jun-22 | Option Sale | 2,327 | $0.64 | $1,494.86 | (< 1%) 283.85K to 281.52K | |
| 03-Jun-22 4:15 PM View: | Rolfe Lindsey See remarks | Clovis Oncology, Inc. (CLVS) | 02-Jun-22 | Option Sale | 2,650 | $0.64 | $1,702.62 | (3%) 105.67K to 103.02K | |
| 03-Jun-22 4:15 PM View: | Gross Paul Edward See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Jun-22 | Option Sale | 2,403 | $0.64 | $1,543.69 | (3%) 87.02K to 84.61K | |
| 03-Jun-22 4:15 PM View: | Muehl Daniel W See remarks | Clovis Oncology, Inc. (CLVS) | 02-Jun-22 | Option Sale | 2,327 | $0.64 | $1,494.86 | (3%) 93.06K to 90.74K | |
| 03-Jun-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 02-Jun-22 | Option Sale | 1,504 | $0.64 | $966.32 | (8%) 19.67K to 18.16K | |
| 03-Jun-22 4:15 PM View: | Rolfe Lindsey See remarks | Clovis Oncology, Inc. (CLVS) | 01-Jun-22 | Option Exercise | 5,062 | -- | -- | 5% 100.6K to 105.67K | |
| 03-Jun-22 4:15 PM View: | Harding Thomas C. See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Jun-22 | Option Exercise | 2,896 | -- | -- | 18% 16.26K to 19.16K | |
| 03-Jun-22 4:15 PM View: | Ivers-Read Gillian C See Remarks | Clovis Oncology, Inc. (CLVS) | 01-Jun-22 | Option Exercise | 5,062 | -- | -- | 2% 278.78K to 283.85K | |
| 03-Jun-22 4:15 PM View: | Muehl Daniel W See remarks | Clovis Oncology, Inc. (CLVS) | 01-Jun-22 | Option Exercise | 5,062 | -- | -- | 6% 88.0K to 93.06K |
